45 studies found for:    Acid Lipase Disease
Show Display Options
Rank Status Study
21 Recruiting Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention:
22 Active, not recruiting Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
Condition: Prevention of Growth Restriction
Interventions: Drug: rhBSSL (recombinant human bile-salt-stimulated lipase);   Drug: Placebo
23 Completed
Has Results
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
Condition: Advanced Melanoma
Interventions: Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Dacarbazine
24 Recruiting Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
25 Suspended Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Condition: Hyperlipoproteinemia Type I
Intervention:
26 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
27 Suspended A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: Conjugated Linoleic Acid;   Drug: Conjugated Linoleic Acid
28 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
29 Unknown  Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: Mycophenolate mofetil;   Drug: cyclosporine
30 Unknown  Following Lipectomy to Understand Adipose Tissue Re-accumulation
Conditions: Menopause;   Pre-menopause
Intervention: Procedure: Femoral lipectomy
31 Recruiting Baby Observational and Nutritional Study
Conditions: Cystic Fibrosis;   Growth Failure;   Exocrine Pancreatic Insufficiency
Interventions: Drug: Pancrelipase 3000 USP units of lipase;   Drug: Pancrelipase 750 USP units of lipase
32 Completed Substrate Cycling in Energy Metabolism
Conditions: Burns;   Insulin Resistance
Intervention: Drug: fenofibrate
33 Terminated
Has Results
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2599506;   Drug: Glyburide;   Drug: Placebo
34 Terminated
Has Results
A Study of LY2599506 in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: LY2599506
35 Completed
Has Results
Fat Perception in Humans (09-0873)
Condition: Obesity
Intervention:
36 Active, not recruiting
Has Results
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GW433908;   Drug: ritonavir
37 Completed Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: MUFA MOVE! (Monounsaturated fatty enriched diet);   Dietary Supplement: PUFA MOVE! (Polyunsaturated fatty acid enriched diet)
38 Unknown  Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Condition: Breast Cancer
Intervention: Drug: Conjugated Linoleic Acid (CLA)
39 Completed Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: mycophenolate mofetil;   Drug: cyclosporine;   Drug: methylprednisolone
40 Completed Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia
Condition: Hyperlipoproteinemia
Interventions: Drug: LCQ908;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years